Truist Financial Corp Sells 6,368 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Truist Financial Corp lowered its stake in Definitive Healthcare Corp. (NASDAQ:DH) by 12.3% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,237 shares of the company’s stock after selling 6,368 shares during the quarter. Truist Financial Corp’s holdings in Definitive Healthcare were worth $247,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Norden Group LLC acquired a new stake in Definitive Healthcare in the first quarter valued at approximately $83,000. Susquehanna Fundamental Investments LLC bought a new position in shares of Definitive Healthcare in the 1st quarter worth $120,000. Canada Pension Plan Investment Board acquired a new stake in Definitive Healthcare in the 2nd quarter valued at $109,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Definitive Healthcare by 31.4% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock valued at $116,000 after purchasing an additional 5,083 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its holdings in Definitive Healthcare by 17.0% during the second quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after buying an additional 3,332 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on DH shares. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a report on Tuesday, August 6th. Robert W. Baird cut their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. JPMorgan Chase & Co. downgraded Definitive Healthcare from a “neutral” rating to an “underweight” rating and lowered their price objective for the stock from $7.00 to $5.00 in a research note on Wednesday, July 31st. Stifel Nicolaus cut their target price on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a research report on Wednesday, July 31st. Finally, Barclays decreased their price target on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $5.81.

Definitive Healthcare Stock Performance

Shares of Definitive Healthcare stock opened at $4.54 on Friday. The firm has a market capitalization of $535.42 million, a P/E ratio of -2.59, a price-to-earnings-growth ratio of 6.27 and a beta of 1.33. The company has a current ratio of 2.40, a quick ratio of 2.40 and a debt-to-equity ratio of 0.27. The business’s fifty day simple moving average is $4.36 and its 200 day simple moving average is $5.34. Definitive Healthcare Corp. has a 12 month low of $3.19 and a 12 month high of $10.62.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.09. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The company had revenue of $63.70 million for the quarter, compared to the consensus estimate of $63.19 million. During the same period in the previous year, the firm earned $0.08 EPS. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. As a group, analysts anticipate that Definitive Healthcare Corp. will post 0.07 EPS for the current year.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.